Ballantyne (BTN) Q1 EPS Increased to $0.07 from $0.04 Last Year
OMAHA, Neb.–(BUSINESS WIRE)–Ballantyne of Omaha, Inc. (NYSE Amex: BTN):
Conference call:
|
Today, Monday, May 3, 2010 at 11:00 a.m. ET
|
|||
Webcast / Replay URL:
|
||||
The replay will be available on the Internet for 90 days. | ||||
Dial-in number:
|
888 222 2795 (no pass code required)
|
|||
Ballantyne Strong, Inc. (NYSE Amex: BTN), a provider of digital cinema projection equipment and services, cinema screens and other cinema products, today reported financial results for the first quarter (Q1) ended March 31, 2010.
First Quarter Results
Largely reflecting an increase in digital cinema equipment sales, net revenues rose 48% to $25.3 million in Q1 2010 from net revenues of $17.1 million in Q1 2009. Ballantyne Strong reported net earnings of approximately $1.0 million, or $0.07 per diluted share, compared to net earnings of approximately $0.5 million, or $0.04 per diluted share a year-ago. Per share results for the first quarters of 2010 and 2009 are based on a weighted average number of diluted shares outstanding of 14,271,617 and 14,111,509, respectively.
Q1 2010 sales of digital cinema equipment rose 137% to $13.8 million from $5.9 million in Q1 2009. The significant increase reflects growing demand for digital projection systems in the Americas and Asia, primarily in China. Demand is being driven largely due to the success in patron traffic and premium pricing that movie exhibitors have been achieving with digital 3D motion pictures and alternative content. Ballantyne’s cinema screen sales increased to $3.5 million during the period, compared to $3.4 million in Q1 2009, as demand for “silver screens” required for most 3D cinema formats remained strong. Revenues from cinema services rose modestly in Q1 2010 to $0.9 million compared to $0.8 million in Q1 2009, primarily due to legacy film equipment services.
Gross profit increased 27% to $4.3 million in Q1 2010, however it declined as a percentage of total revenue to 17.0%, from 19.7% in Q1 2009. The gross profit margin decline was largely due to an increasing contribution from the sale of digital cinema projection equipment. While this equipment carries lower profit margins than other Ballantyne products or services, the Company expects that this impact on gross profit dollars should be largely offset by projection equipment’s higher sales price and volume.
Q1 2010 SG&A declined nominally to $2.7 million, but fell significantly as a percentage of net revenues to 10.7%, compared to 16.0% in Q1 2009. Ballantyne continues to work to limit the growth in SG&A expenses in order to drive operating leverage from anticipated increases in revenues.
Balance Sheet Update
Ballantyne had $22.8 million in cash and cash equivalents at March 31, 2010, compared to $23.6 million at December 31, 2009. The decrease in cash is primarily related to short-term working capital needs to fund an increase in receivables that resulted from growth in business during the quarter.
Outlook
John P. Wilmers, President and CEO, stated, “We are off to a strong start for 2010 and believe Q1 2010 is an early indication of how Ballantyne Strong is well-positioned to benefit from our evolution into a turnkey, worldwide provider of digital projection equipment and services. The global growth trajectory of digital cinema is gaining momentum as expected, and we are seeing increasing opportunities in equipment and cinema screen sales, installations and integrations, and related digital cinema service opportunities.
“Our business in Asia also made strong contributions to our performance during the first quarter as China continues to move aggressively to convert cinemas to digital technology. We continue to view China and neighboring Asian territories as exciting growth opportunities for Ballantyne Strong and are actively working to increase projector and related digital cinema product and service sales in the region.
“In mid-April we launched a large-scale, multi-year digital projector installation and integration project for a leading exhibitor in the Americas. This project should amount to at least 900 installations for the balance of 2010 and an even larger number in 2011 and 2012. This baseline of activity for our team of skilled technicians will make a substantial contribution to the performance of Ballantyne’s growing service business this year and going forward.”
About Ballantyne Strong, Inc. (http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ballantyne-strong.com&esheet=6273527&lan=en_US&anchor=www.ballantyne-strong.com&index=3&md5=1bc93e1db7c64deacc0a7a2b6a450f9f)
Ballantyne Strong is a provider of digital cinema projection equipment and services as well as cinema screens, motion picture projectors and specialty lighting equipment and services. The Company supplies major and independent theater chains, top arenas, theme parks and architectural sites around the world.
Except for the historical information in this press release, it includes forward-looking statements that involve risks and uncertainties, including but not limited to, quarterly fluctuations in results; customer demand for the Company’s products; the development of new technology for alternate means of motion picture presentation; domestic and international economic conditions; the management of growth; and other risks detailed from time to time in the Company’s Securities and Exchange Commission filings. Actual results may differ materially from management’s expectations.
Ballantyne Strong, Inc. and Subsidiaries
|
||||||||
Consolidated Statements of Operations
|
||||||||
(unaudited)
|
||||||||
Three Months Ended
March 31,
|
||||||||
2010 | 2009 | |||||||
Net revenues | $ | 25,337,509 | $ | 17,143,453 | ||||
Cost of revenues | 21,041,973 | 13,764,383 | ||||||
Gross profit | 4,295,536 | 3,379,070 | ||||||
Selling and administrative expenses: | ||||||||
Selling | 714,835 | 668,399 | ||||||
Administrative | 2,000,783 | 2,076,660 | ||||||
Total selling and administrative expenses | 2,715,618 | 2,745,059 | ||||||
Income from operations | 1,579,918 | 634,011 | ||||||
Interest income | 3,765 | 41,130 | ||||||
Interest expense | (7,817 | ) | (8,113 | ) | ||||
Equity in loss of joint venture | (158,598 | ) | (184,512 | ) | ||||
Other income (expense), net | (44,017 | ) | 181,237 | |||||
Earnings before income taxes | 1,373,251 | 663,753 | ||||||
Income tax expense | (374,401 | ) | (122,034 | ) | ||||
Net earnings | $ | 998,850 | $ | 541,719 | ||||
Earnings per share | ||||||||
Basic | $ | 0.07 | $ | 0.04 | ||||
Diluted | $ | 0.07 | $ | 0.04 | ||||
Weighted average shares outstanding: | ||||||||
Basic | 14,074,997 | 13,988,206 | ||||||
Diluted | 14,271,617 | 14,111,509 |
Ballantyne Strong, Inc. and Subsidiaries
|
||||||||
Consolidated Balance Sheets
|
||||||||
Assets
|
Mar. 31, 2010 | Dec. 31, 2009 | ||||||
Current assets: | (Unaudited) | |||||||
Cash and cash equivalents | $ | 22,752,101 | $ | 23,589,025 | ||||
Restricted cash | 442,766 | 442,766 | ||||||
Accounts receivable | 17,460,752 | 8,877,980 | ||||||
Unbilled revenue | 3,665,001 | 1,894,075 | ||||||
Inventories, net | 12,298,126 | 12,987,048 | ||||||
Recoverable income taxes | 1,836,016 | 1,850,699 | ||||||
Deferred income taxes | 2,010,028 | 1,943,679 | ||||||
Consignment inventory | 721,936 | 486,527 | ||||||
Other current assets | 1,231,724 | 667,592 | ||||||
Total current assets | 62,418,450 | 52,739,391 | ||||||
Investment in joint venture | 2,058,040 | 2,216,638 | ||||||
Property, plant and equipment, net | 3,608,494 | 3,612,935 | ||||||
Intangible assets, net | 1,021,080 | 1,103,128 | ||||||
Other assets | 17,257 | 17,257 | ||||||
Deferred income taxes | 604,781 | 520,951 | ||||||
Total assets | $ | 69,728,102 | $ | 60,210,300 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 17,723,762 | $ | 9,768,896 | ||||
Other accrued expenses | 3,383,652 | 3,623,143 | ||||||
Customer deposits | 3,452,012 | 2,295,946 | ||||||
Income tax payable | 508,326 | 1,246,247 | ||||||
Total current liabilities | 25,067,752 | 16,934,232 | ||||||
Deferred income taxes | 277,614 | 274,977 | ||||||
Other accrued expenses, net of current portion | 473,517 | 483,425 | ||||||
Total liabilities | 25,818,883 | 17,692,634 | ||||||
Commitments and contingencies | ||||||||
Stockholders’ equity: | ||||||||
Preferred stock, par value $.01 per share; Authorized 1,000,000 shares, none
|
||||||||
outstanding
|
— | — | ||||||
Common stock, par value $.01 per share; Authorized 25,000,000 shares;
|
||||||||
issued 16,324,706 shares in 2010 and 16,283,676 shares in 2009
|
163,247 | 162,836 | ||||||
Additional paid-in capital | 35,485,509 | 35,332,787 | ||||||
Accumulated other comprehensive income (loss): | ||||||||
Foreign currency translation | (46,516 | ) | (286,086 | ) | ||||
Minimum pension liability | 110,665 | 110,665 | ||||||
Retained earnings | 23,578,994 | 22,580,144 | ||||||
59,291,899 | 57,900,346 | |||||||
Less 2,139,982 of common shares in treasury, at cost | (15,382,680 | ) | (15,382,680 | ) | ||||
Total stockholders’ equity | 43,909,219 | 42,517,666 | ||||||
Total liabilities and stockholders’ equity | $ | 69,728,102 | $ | 60,210,300 |
Selected Cash Flow Statement Items (unaudited):
|
||||||
Three Months Ended
March 31,
|
||||||
2010 | 2009 | |||||
Net income | $ | 998,850 | $ | 541,719 | ||
Depreciation and amortization | 398,286 | 459,366 | ||||
Equity in loss in Digital Link II Joint Venture | 158,598 | 184,512 | ||||
Net cash used in operating activities | (751,470) | (215,867) | ||||
Capital expenditures | (148,206) | (274,847) | ||||
Proceeds from sales of investment securities | – | 450,000 | ||||
Net cash provided by (used in) investing activities | (148,206) | 184,481 | ||||
Net decrease in cash & cash equivalents | (836,924) | (75,030) | ||||
Cash & cash equivalents at beginning of period | 23,589,025 | 11,424,984 | ||||
Cash & cash equivalents at end of period | $ | 22,752,101 | $ | 11,349,954 |
TraderPower Featured Companies
- Annovis Bio Inc. (NYSE: ANVS)
- Astrotech Corp. (NASDAQ: ASTC)
- Cepton Inc. (NASDAQ: CPTN)
- Clene Inc. (NASDAQ: CLNN)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)
- Fintech Ecosystem Development Corp. (NASDAQ: FEXD)
- Freight Technologies Inc. (NASDAQ: FRGT)
- InMed Pharmaceuticals Inc. (NASDAQ: INM)
- Lexaria Bioscience Corp. (NASDAQ: LEXX)
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)
- Mullen Automotive Inc. (NASDAQ: MULN)
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
Top Small Cap Market News
- $ANVS Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast
- $SCNI InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
- $INM InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
- $SFWJ Hemp Industry Says Missouri Governor ‘Overreached’ When Banning Hemp Intoxicants
- $RFHRF InvestorNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities
- $MUX InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources
- $ECGI InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’
Recent Posts
- $ECGI InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’
- $MUX InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources
- $RFHRF InvestorNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities
- $SFWJ Hemp Industry Says Missouri Governor ‘Overreached’ When Banning Hemp Intoxicants
- $INM InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
- $SCNI InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
- $ANVS Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast
- $FLGC CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space
Recent Comments
Archives
- August 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009